Clinical Trials Browser

Not yet recruiting × Interventional × Brentuximab Vedotin × Clear all

NCT07178457 2025-09-17

BeCALM

Phase 3 Not yet recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence